The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology
暂无分享,去创建一个
G. Filippatos | A. Mebazaa | M. Metra | A. Coats | P. Seferovic | F. Ruschitzka | P. Rossignol | H. Brunner-La Rocca | F. Orso | P. Martens | W. Mullens | V. Harjola | K. Damman | J. Testani | W. Tang | H. Brunner‐La Rocca | Pieter Martens
[1] S. Morell,et al. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study. , 2016, JACC. Heart failure.
[2] Jeffrey M. Turner,et al. Loop Diuretic Efficiency: A Metric of Diuretic Responsiveness With Prognostic Importance in Acute Decompensated Heart Failure , 2014, Circulation. Heart failure.
[3] W. Tang,et al. Urinary Composition During Decongestive Treatment in Heart Failure With Reduced Ejection Fraction , 2014, Circulation. Heart failure.
[4] D. Ellison,et al. The WNK kinase network regulating sodium, potassium, and blood pressure. , 2011, Journal of the American Society of Nephrology : JASN.
[5] G. Fonarow,et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. , 2007, European heart journal.
[6] Q. Swennen,et al. The kidney in congestive heart failure: ‘are natriuresis, sodium, and diuretics really the good, the bad and the ugly?’ , 2014, European journal of heart failure.
[7] K. Damman,et al. The kidney in heart failure: an update. , 2015, European heart journal.
[8] W. Tang,et al. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. , 2014, Journal of cardiac failure.
[9] M. Pfisterer,et al. Use of B-type natriuretic peptide outside of the emergency department. , 2008, International journal of cardiology.
[10] N. Benowitz,et al. Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics , 1991, Cardiovascular Drugs and Therapy.
[11] F. Wilson,et al. An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial. , 2017, International journal of cardiology.
[12] J. Waniewski,et al. Kinetics of Plasma Refilling During Hemodialysis Sessions with Different Initial Fluid Status , 2015, ASAIO journal.
[13] J. Massaro,et al. Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload. , 2017, Journal of the American College of Cardiology.
[14] K. Tabei,et al. A study on regulating factors of plasma refilling during hemodialysis. , 1996, Nephron.
[15] P. Martens,et al. Insights into implementation of sacubitril/valsartan into clinical practice , 2018, ESC heart failure.
[16] V. Hasselblad,et al. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. , 2005, Journal of cardiac failure.
[17] C. O'connor,et al. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From ASCEND-HF. , 2016, JACC. Heart failure.
[18] M. Lainscak,et al. Cardiac cachexia: hic et nunc: "hic et nunc" - here and now. , 2015, International journal of cardiology.
[19] K. Anstrom,et al. Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial , 2017, JAMA cardiology.
[20] Brater Dc. Pharmacokinetics of loop diuretics in congestive heart failure , 1994 .
[21] C. Mathieu,et al. Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and Beyond , 2017, Current Treatment Options in Cardiovascular Medicine.
[22] K. White,et al. Clinical epidemiology. , 1983, International journal of epidemiology.
[23] G. Filippatos,et al. Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study. , 2016, Journal of the American College of Cardiology.
[24] E. Mutschler,et al. Pharmacodynamic and kinetic considerations on diuretics as a basis for differential therapy , 1991, Klinische Wochenschrift.
[25] Rui Placido,et al. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion , 2018, European journal of heart failure.
[26] K. Mahaffey,et al. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes , 2017, The New England journal of medicine.
[27] H. Krumholz,et al. Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives? , 2013, Journal of the American College of Cardiology.
[28] K. Anstrom,et al. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). , 2015, Circulation. Heart failure.
[29] W. Tang,et al. Spironolactone to increase natriuresis in congestive heart failure with cardiorenal syndrome , 2019, Acta cardiologica.
[30] M. Fischereder,et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2016, The New England journal of medicine.
[31] F. Wilson,et al. Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure , 2016, Circulation. Heart failure.
[32] F. Verbrugge,et al. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions. , 2017, The American journal of cardiology.
[33] L. Stevenson,et al. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.
[34] C. O'connor,et al. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury , 2018, Circulation.
[35] A. Voors,et al. Bio‐adrenomedullin as a potential quick, reliable, and objective marker of congestion in heart failure , 2018, European journal of heart failure.
[36] G. Volpicelli,et al. Lung Ultrasound Predicts Well Extravascular Lung Water but Is of Limited Usefulness in the Prediction of Wedge Pressure , 2014, Anesthesiology.
[37] A. Ducharme,et al. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials. , 2006, American heart journal.
[38] R. Matsukawa,et al. Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure. , 2017, Journal of the American College of Cardiology.
[39] J. Rouleau,et al. Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF trial (atrial fibrillation and chronic heart failure). , 2014, JACC. Heart failure.
[40] K. Swedberg,et al. Salt and fluid restriction is effective in patients with chronic heart failure , 2013, European journal of heart failure.
[41] F. Sarullo,et al. Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compensated Heart Failure With New York Heart Association Class III (Class C) (SMAC-HF Study) , 2011, The American journal of the medical sciences.
[42] Nancy M Albert,et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. , 2010, Journal of cardiac failure.
[43] X. Qian,et al. Liberal versus restricted fluid administration in heart failure patients. A systematic review and meta-analysis of randomized trials. , 2015, International heart journal.
[44] R. Agarwal,et al. Thiazide diuretics in advanced chronic kidney disease. , 2012, Journal of the American Society of Hypertension : JASH.
[45] A. Hoes,et al. Clinical epidemiology of heart failure , 2007, Heart.
[46] A. Odermatt,et al. Rapid dephosphorylation of the renal sodium chloride cotransporter in response to oral potassium intake in mice. , 2013, Kidney international.
[47] M. Vaduganathan,et al. Water and Sodium in Heart Failure: A Spotlight on Congestion , 2014, Heart Failure Reviews.
[48] W. Zoghbi,et al. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. , 1994, The American journal of cardiology.
[49] G. Felker,et al. Diuretics and ultrafiltration in acute decompensated heart failure. , 2012, Journal of the American College of Cardiology.
[50] Adrian F Hernandez,et al. Diuretic strategies in patients with acute decompensated heart failure. , 2011, The New England journal of medicine.
[51] W. Tang,et al. The pathophysiological role of interstitial sodium in heart failure. , 2015, Journal of the American College of Cardiology.
[52] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[53] C. Lindsell,et al. Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. , 2006, Annals of emergency medicine.
[54] K. Anstrom,et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. , 2012, The New England journal of medicine.
[55] P. Ponikowski,et al. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. , 2018, International journal of cardiology.
[56] F. Zannad,et al. Lack of Diuretic Efficiency (but Not Low Diuresis) Early in An Acutely Decompensated Heart Failure Episode Is Associated with Increased 180-Day Mortality , 2016, Cardiorenal Medicine.
[57] Y. Pinto,et al. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?) , 2018, Circulation.
[58] M. Drazner,et al. The Role of the Clinical Examination in Patients With Heart Failure. , 2018, JACC. Heart failure.
[59] Andreas Schäfer,et al. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) , 2017, European journal of heart failure.
[60] Divya Gupta,et al. Dietary Sodium Intake in Heart Failure , 2012, Circulation.
[61] M. Drazner,et al. Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per‐protocol analysis of CARRESS‐HF , 2018, European journal of heart failure.
[62] W. Tang,et al. Hyponatremia in acute decompensated heart failure: depletion versus dilution. , 2015, Journal of the American College of Cardiology.
[63] W. Tang,et al. Prognostic value of glomerular filtration changes versus natriuretic response in decompensated heart failure with reduced ejection. , 2014, Journal of cardiac failure.
[64] J. McMurray,et al. Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.
[65] S. Barbic,et al. Point-of-care ultrasonography for the diagnosis of acute cardiogenic pulmonary edema in patients presenting with acute dyspnea: a systematic review and meta-analysis. , 2014, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[66] Akshay S. Desai,et al. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit. , 2016, JACC. Heart failure.
[67] Jacob P. Kelly,et al. Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). , 2017, The American journal of cardiology.
[68] P. Ponikowski,et al. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine , 2010, European journal of heart failure.
[69] G. Fonarow,et al. Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure. , 2016, JACC. Heart failure.
[70] F. Wilson,et al. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure , 2016, Circulation. Heart failure.
[71] J. Soler‐Soler,et al. Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction , 2005, European journal of heart failure.
[72] J. McMurray,et al. Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review , 2017, European journal of heart failure.
[73] K. Swedberg,et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. , 2013, European heart journal.
[74] P. Ponikowski,et al. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT‐CHF , 2017, European journal of heart failure.
[75] Adrian F Hernandez,et al. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. , 2017, JACC. Heart failure.
[76] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[77] Piotr Ponikowski,et al. EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot) , 2013, European journal of heart failure.
[78] M. Drazner,et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. , 2001, The New England journal of medicine.
[79] Adrian F. Hernandez,et al. Combination of loop diuretics with thiazide-type diuretics in heart failure. , 2010, Journal of the American College of Cardiology.
[80] R. Starling,et al. Transient Hyponatremia During Hospitalization for Acute Heart Failure. , 2016, The American journal of medicine.
[81] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[82] E. Mutschler,et al. Sequential nephron blockade breaks resistance to diuretics in edematous states. , 1997, Journal of cardiovascular pharmacology.
[83] F. Verbrugge,et al. Value of routine investigations to predict loop diuretic down-titration success in stable heart failure. , 2018, International journal of cardiology.
[84] S. McGee. Physical examination of venous pressure: a critical review. , 1998, American heart journal.
[85] D. Brater. Pharmacokinetics of loop diuretics in congestive heart failure. , 1994, British heart journal.
[86] G. Felker,et al. Diuretic Treatment in Heart Failure. , 2017, The New England journal of medicine.
[87] G. Filippatos,et al. Renal dysfunction and heart failure: things are seldom what they seem. , 2014, European heart journal.
[88] W. Tang,et al. Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low , 2018, Acta cardiologica.
[89] M. Isobe,et al. Progression of hyponatremia is associated with increased cardiac mortality in patients hospitalized for acute decompensated heart failure. , 2012, Journal of cardiac failure.
[90] M. Gheorghiade,et al. Moving away from symptoms‐based heart failure treatment: misperceptions and real risks for patients with heart failure , 2016, European journal of heart failure.
[91] William T. Abraham,et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness , 2005 .
[92] M. Gheorghiade,et al. Acute heart failure syndromes , 2009, Journal of the American College of Cardiology.
[93] D. Ellison. Diuretic Therapy and Resistance in Congestive Heart Failure , 2002, Cardiology.
[94] Manesh R. Patel,et al. Splanchnic Nerve Block for Acute Heart Failure. , 2018, Circulation.
[95] G. Filippatos,et al. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial , 2018, European journal of heart failure.
[96] P. Ponikowski,et al. Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure , 2016, Circulation. Heart failure.
[97] M. Zile,et al. Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial. , 2016, Journal of cardiac failure.
[98] Akshay S. Desai,et al. Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit. , 2018, Journal of cardiac failure.
[99] S. Houser,et al. Outcomes Associated With a Strategy of Adjuvant Metolazone or High‐Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis , 2018, Journal of the American Heart Association.
[100] G. Fonarow,et al. Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure , 2017, Journal of the American College of Cardiology.
[101] G. Filippatos,et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry , 2017, European journal of heart failure.
[102] F. Verbrugge,et al. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. , 2013, Journal of the American College of Cardiology.
[103] P. Vandervoort,et al. Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload , 2015, Acta cardiologica.
[104] R. Wenzel. Diuretics in heart failure. , 1986, Lancet.
[105] A. Cohen-Solal,et al. Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure. , 2015, International journal of cardiology.
[106] K. Rentsch,et al. Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function , 2017, European journal of heart failure.
[107] Akshay S. Desai,et al. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring. , 2016, JACC. Heart failure.
[108] G. Filippatos,et al. Haemoconcentration, renal function, and post‐discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial , 2013, European journal of heart failure.
[109] B. Zinman,et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.
[110] G. Alunni,et al. Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure , 2015, European journal of heart failure.
[111] S. Kimmel,et al. Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival , 2010, Circulation.
[112] K. Swedberg,et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. , 2007, JAMA.
[113] S. Bachmann,et al. Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. , 1985, The American journal of physiology.
[114] J. Nanas,et al. Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a randomized study. , 2014, International journal of cardiology.
[115] R. Starling,et al. Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. , 2012, Journal of the American College of Cardiology.
[116] W. Tang,et al. Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure Treatment. , 2015, The American journal of medicine.
[117] Gary S Francis,et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.
[118] G. Filippatos,et al. Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction , 2009, Clinical Research in Cardiology.
[119] J. McMurray,et al. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction , 2016, European journal of heart failure.
[120] M. Metra,et al. Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?: The Role of Congestion and Its Interaction With Renal Function , 2012, Circulation. Heart failure.
[121] P. Martens,et al. How to tackle congestion in acute heart failure , 2018, The Korean journal of internal medicine.
[122] Volkmar Falk,et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.
[123] F. Verbrugge,et al. Renal sodium avidity in heart failure: from pathophysiology to treatment strategies , 2017, European heart journal.
[124] Gerasimos Filippatos,et al. Pathophysiologic targets in the early phase of acute heart failure syndromes. , 2005, The American journal of cardiology.
[125] P. Martens,et al. Current Approach to Decongestive Therapy in Acute Heart Failure , 2015, Current Heart Failure Reports.
[126] S. Russell,et al. Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure. , 2018, JACC. Heart failure.
[127] Paaladinesh Thavendiranathan,et al. Prediction of 30-day heart failure-specific readmission risk by echocardiographic parameters. , 2014, The American journal of cardiology.
[128] H. Krum,et al. Effect of beta‐adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial , 2017, Journal of cachexia, sarcopenia and muscle.
[129] G. Navis,et al. Diuretic response in acute heart failure—pathophysiology, evaluation, and therapy , 2015, Nature Reviews Cardiology.
[130] C. Parikh,et al. Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. , 2013, Journal of the American College of Cardiology.
[131] M. Chen,et al. Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure. , 2017, Journal of the American Society of Nephrology : JASN.
[132] S. Nagueh. Non‐invasive assessment of left ventricular filling pressure , 2018, European journal of heart failure.
[133] Akshay S. Desai,et al. Are Serial BNP Measurements Useful in Heart Failure Management?: Serial Natriuretic Peptide Measurements Are Not Useful in Heart Failure Management The Art of Medicine Remains Long , 2013, Circulation.
[134] R. Myerburg,et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. , 1991, The American journal of medicine.
[135] James D. Thomas,et al. Tissue Doppler Imaging in the Estimation of Intracardiac Filling Pressure in Decompensated Patients With Advanced Systolic Heart Failure , 2009, Circulation.
[136] M. Vaduganathan,et al. Hemoconcentration-guided diuresis in heart failure. , 2014, American Journal of Medicine.
[137] J. Ferreira,et al. Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure. , 2014, European journal of internal medicine.
[138] Sanjiv J. Shah,et al. The potential role and rationale for treatment of heart failure with sodium–glucose co‐transporter 2 inhibitors , 2017, European journal of heart failure.
[139] Monica R. Shah,et al. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness The ESCAPE Trial , 2005 .
[140] G. Filippatos,et al. An introduction to acute heart failure syndromes: definition and classification , 2007, Heart Failure Reviews.
[141] J. Cleland,et al. The effects of short‐term omission of daily medication on the pathophysiology of heart failure , 2017, European journal of heart failure.
[142] M. Böhm,et al. A real-world perspective on the prevalence and treatment of heart failure with a reduced ejection fraction but no specific or only mild symptoms , 2015, Heart Failure Reviews.
[143] J. Concato,et al. Patterns of Weight Change Preceding Hospitalization for Heart Failure , 2007, Circulation.
[144] N. Bayley,et al. Failure , 1890, The Hospital.
[145] W. Miller. Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed. , 2016, Circulation. Heart failure.
[146] G. Fonarow,et al. Differential prognostic effect of systolic blood pressure on mortality according to left‐ventricular function in patients with acute heart failure , 2010, European journal of heart failure.
[147] K. Anstrom,et al. Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure. , 2016, Journal of cardiac failure.
[148] K. Anstrom,et al. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights from DOSE-AHF and CARRESS-HF , 2015 .
[149] R. Guthrie. Canagliflozin and cardiovascular and renal events in type 2 diabetes , 2018, Postgraduate medicine.
[150] R. Roberts,et al. Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure. , 2017, Journal of the American College of Cardiology.
[151] E. Colín-Ramírez,et al. Salt in the diet in patients with heart failure: what to recommend , 2016, Current opinion in cardiology.
[152] G. Navis,et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. , 2009, Journal of the American College of Cardiology.